Disarm Therapeutics was co-founded by Jeffrey Milbrandt, MD, PhD, and Aaron DiAntonio, MD, PhD, to speed the development of treatments for multiple neurodegenerative conditions.
It marks one of the largest funding rounds for a St. Louis startup in 2020.
SEI Lab has been awarded a $200,000 grant to explore and document how entrepreneurship affects equity and mobility.
A COVID-19 vaccine developed at Washington University in St. Louis School of Medicine has been licensed by St. Louis biotech startup Precision Virologics.
Applications are now open for the Skandalaris Venture Competition (SVC). Up to $22,500 in awards available.
Opendoor, cofounded by WashU alum JD Ross, will gain a $1 billion infusion in an acquisition that values the company at nearly $5 billion.
More great ink for Washington University in St Louis inventors Jen and Jon Silva.
Washington University in St. Louis alum and entrepreneur Morgan DeBaun talks about venture-capital funding for Black founders.
The new test is faster and simpler than nasal and oral swab tests and enables screening on a massive scale.